Mycosis Fungoides
📧 Sign up to get email alerts when something new happens for Mycosis Fungoides.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma
A real-world study reports on the use of mogamulizumab for treating cutaneous T-cell lymphoma and its subtypes.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
A clinical trial update notes ongoing recruitment for systemic therapies in the treatment of cutaneous T-cell lymphoma, including mycosis fu…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: IL-35: A Key Immunosuppressive Driver in Mycosis Fungoides Modulated by Phototherapy [NA]
A completed clinical trial update investigates interleukin-35 as a key immunosuppressive driver in mycosis fungoides and how phototherapy mo…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas [Phase 2]
Clinical trial update indicates a Phase 2 study of the JAK1 inhibitor golidocitnib for relapsed/refractory indolent T- and NK-cell lymphomas…
-
CLINICAL_TRIALS research · 2025-10-22Clinical Trial Update: ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
This Stanford University clinical trial aims to identify prognostic factors in Mycosis fungoides and Sézary syndrome and is currently recrui…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-16Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment [Phase 1, Phase 2]
The NCI-announced Phase 1/2 trial testing magrolimab added to mogamulizumab for recurrent or refractory Mycosis Fungoides/Sezary Syndrome wa…
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma [Phase 2]
Phase 2 trial evaluating the combination of extracorporeal photopheresis and mogamulizumab for erythrodermic cutaneous T-cell lymphoma, curr…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: A Phase 1, Multicenter, Open-label, Prospective, First-in-human Dose-escalation Clinical Trial of Domain Therapeutics' Anti-CCR8 Monoclonal Antibody (DT-7012) in Patients With Relapsed or Refractory Cutaneous T-cell Lymphomas (CTCL) [EARLY_Phase 1]
A first-in-human Phase 1 dose-escalation study of DT-7012, a CCR8-targeting monoclonal antibody from Domain Therapeutics, in relapsed or ref…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas [Phase 1, Phase 2]
This is a completed Phase 1/2 clinical trial from MD Anderson evaluating AFM13 and AFM13-NK in patients with recurrent or refractory CD30-po…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Photopheresis in Early-stage Mycosis Fungoides [Phase 2]
Phase 2 trial evaluating photopheresis in early-stage mycosis fungoides (cutaneous T cell lymphoma) is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of ST-001 nanoFenretinide for relapsed/refractory T-cell non-Hodgkin lymphoma is currently recruiting, targeting multiple T-ce…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance
A clinical trial update on mogamulizumab (Poteligeo) assessing safety and efficacy through use-result surveillance in patients with mycosis …
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating durvalumab with or without lenalidomide in patients with relapsed or refractory cutaneous or periph…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy [Phase 4]
Phase 4 update evaluating KW-0761 (mogamulizumab) for Mycosis fungoides or Sézary syndrome in Chinese patients who have previously received …
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
A US-based prospective study examining mogamulizumab-associated rash in patients with mycosis fungoides or Sézary syndrome who are treated w…
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL [Phase 2]
Phase 2 trial comparing HyBryte (synthetic hypericin) to Valchlor (mechlorethamine gel) for Cutaneous T-Cell Lymphoma/Mycosis Fungoides has …
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
A prospective exploratory biomarker study called SKINERGY sponsored by Leiden University Medical Center is recruiting to profile skin diseas…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides [Phase 2]
Phase 2 trial evaluating pembrolizumab in patients with stage IB-IV mycosis fungoides and Sezary syndrome has completed, with results posted…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Ritlecitinib in CTCL [Phase 2]
A Phase 2 trial of ritlecitinib for cutaneous T-cell lymphoma was terminated.
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: Long-term Assessment of Chlormethine Gel in Mycosis Fungoides
This clinical trial update outlines a long-term assessment of chlormethine gel (mechlorethamine) for treating mycosis fungoides, a form of c…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome [Phase 2]
Clinical trial evaluating mogamulizumab with low-dose total skin electron beam therapy in Sézary syndrome and mycosis fungoides, Phase 2, cu…
-
CLINICAL_TRIALS withdrawal · 2025-06-27Clinical Trial Update: BIOmarker-guided Study to Evaluate the Efficacy and Safety of cemipLimab for advancEd Cutaneous T-cell Lymphoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating cemiplimab for advanced cutaneous T-cell lymphoma (Mycosis fungoides) has been withdrawn (NCT05538988)…
-
CLINICAL_TRIALS withdrawal · 2025-06-12Clinical Trial Update: Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System. [NA]
A clinical trial evaluating Triamcinolone acetonide injections with a novel needle-free delivery system for primary cutaneous lymphoma plaqu…
-
CLINICAL_TRIALS trial_result · 2025-05-26Clinical Trial Update: Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating direct tumor microinjection and FDG-PET to test drug sensitivity in patients with relapsed or refractory n…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: A Registry for People With T-cell Lymphoma
A registry study at Memorial Sloan Kettering Cancer Center to enroll people with various T-cell and NK-cell lymphomas; the trial is currentl…